Advertisement

The evolution of JISAKOS continues

Open AccessPublished:September 09, 2022DOI:https://doi.org/10.1016/j.jisako.2022.08.005

      1. Transition to Gold Open Access and new 100% member discount

      As you may have noticed, JISAKOS moved to a Gold Open Access model as of January 2022. This means that authors who publish in JISAKOS will have their research and articles made immediately and permanently freely accessible worldwide. JISAKOS authors will pay an article publishing charge (APC), have a choice of license options, and will retain copyright to their published works. The APC will be requested after the article has been peer reviewed and accepted. Now, here is the exciting new development: The APC will be $1500 for full-length articles and $750 for shorter articles, such as case reports, technical notes, and surgical technique video submissions. As a member benefit, ISAKOS members initially received a 20% discount on the fees. But our Board recently met and approved, for a limited time through December 2023, to provide ISAKOS members with a 100% discount on the APC, meaning that corresponding authors who are members will not pay any open access publication fees to publish in JISAKOS!
      We also want to encourage non-members to submit and have worked hard to come up with solutions for authors who may reside in countries that are challenged economically. One solution is that Elsevier participates in Research4Life, which is a program that can help authors in developing countries get access to funding and discounts, as well as potential fee waivers. In addition, Elsevier has transformative agreements with certain institutions around the world, wherein medical professionals at those institutions have access to discounts and in some cases full waivers on the open access publication fees. All of this is outlined and explained on the new JISAKOS website, www.jisakos.com, in our Author APC Guide document.

      2. JISAKOS Associate Editors, social media, and theme issues

      Another change we are making is the appointment of Associate Editors who serve as handling editors for manuscripts, and who will serve as guest editors of theme issues within the journal. Our Editorial Board, as well as the key positions within it, can be viewed at https://www.jisakos.com/content/edboard.
      We have revamped our editorial board and increased our social media efforts, in order to continue to develop content for our journal podcast and ensure that we are leveraging the strength of Open Access to make our content more widely discoverable, readable, applicable, and shareable. One of the benefits of Open Access is that the articles do not have any paywall, so they are freely available to read and share. I have always been frustrated when someone shares an article and when I click on the link, it tells me I have to pay a fee to read that article. With JISAKOS that will not happen because the articles are openly available! Speaking of social media, be sure to like us and follow us on Facebook (https://www.facebook.com/JISAKOS/) and Twitter (https://twitter.com/J_ISAKOS or @J_ISAKOS). We appreciate all of your likes, comments, and shares.
      The other exciting new development is the JISAKOS Theme Issues. These will be topic-focused groups of articles that come from the ISAKOS Clinical Committees. Each Committee will propose a Guest Editor and topics to me, and upon approval, will develop a series of articles for that special issue. For example, an ideal Theme Issue would include a mix of article types, such as a state-of-the-art article, one or two systematic reviews, a current concept review article, a surgical technique video, a case report, and one classic. These special issues will support our growing community of readers and ISAKOS members with clinically relevant content for best practice. If you would like to learn more about special issues and how you can propose a topic or contribute to a special issue from an ISAKOS committee, please visit this site: https://www.elsevier.com/authors/submit-your-paper/special-issues and email me at c.niekvandijk@jisakos.com .

      Conflict of interest

      No conflict of interest.